Dr. Yuri Reznik, MD

Dr. Reznik practices at Arroyo Vista Nursing Center in San Diego, California.

Dr. Reznik's NPI, 1871618207, was assigned on March 21, 2007. Dr. Reznik graduated from Autonomous University of Baja California School of Medicine in 2005. Dr. Reznik holds California license A105767.

Dr. Reznik's primary practice is Arroyo Vista Nursing Center, at 3022 45th Street, San Diego, CA 92105 in San Diego County. The practice phone is (619) 283-5855.

Dr. Reznik's primary practice is Arroyo Vista Nursing Center in San Diego, California. Dr. Reznik is also affiliated with Scripps Mercy Hospital San Diego. The medical group on file is Vituity. Dmand AI also links Dr. Reznik to 7 more medical groups, 5 group practices and clinics, 4 skilled nursing facilities, 1 community health center and 1 hospice, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Reznik practices, 13 sites in all. Vendor and product names are available with a free account.

Hospitalist is Dr. Reznik's primary specialty in the NPI Registry, under taxonomy code 208M00000X. Dr. Reznik is board certified in family medicine by the American Board of Family Medicine. Dmand AI has Dr. Reznik's licenses on file in 2 states: California and Nevada.

Dmand AI lists anemia, cellulitis, congestive heart failure, electrolyte disorders, gastrointestinal bleeding, inflammatory bowel disease (IBD), non-surgical back problems and pneumonia and respiratory infection among the conditions Dr. Reznik treats.

CMS data shows 921 Medicare services from Dr. Reznik across 9 procedure codes in 2024, for 350 Medicare patients. Medicare paid $78,200 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 350 Medicare patients who saw Dr. Reznik in 2024. The largest group is 65 to 74, with 125 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 57% are also on Medicaid. Their average risk score is 2.64, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Reznik's median patient age at 76, with 49% women.

In 2024, Dr. Reznik wrote 1,118 Medicare Part D claims for 170 patients. 83% of them were for generic drugs. CMS names the drug for 759 of them, across 30 drugs with 11 or more claims each, at $27,615 in total drug cost. In 2023, CMS named 835 claims across 35 drugs.

Dr. Reznik accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Dmand AI links 3 papers to Dr. Reznik in 2016. 2016 was the busiest year, with 2. The most frequent topics are Glycated Hemoglobin, Insulin and Diabetes Mellitus, Type 2. Dr. Reznik has published most often in Diabetes Obes Metab. Dr. Reznik's most frequent co-author is Denis Marcel Morin, MD.

Dr. Reznik graduated from Autonomous University of Baja California School of Medicine in 2005.

Dr. Reznik is in network with 8 carriers, including Aetna, Blue Cross Blue Shield of Michigan and United Healthcare. Medicare plans come from the most carriers, 7. Check the plan with the practice before a visit.